Harvey Friedman provides hope for an HSV Vaccine at the University of Pennsylvania

Researchers, led by Dr. Harvey Friedman, from the Perelman School of Medicine at the University of Pennsylvania are close to clinical trials testing a vaccine protecting against genital herpes. PhaseContinueContinue reading “Harvey Friedman provides hope for an HSV Vaccine at the University of Pennsylvania”

“Moving Beyond a 45 year old antiviral” Article in BioCentury Magazine

Herpes Cure Advocacy win! Our team worked with editors at Biocentury magazine on this article. Enjoy! “After a decades long lull in innovation, a wave of candidates is advancing throughContinueContinue reading ““Moving Beyond a 45 year old antiviral” Article in BioCentury Magazine”

Key Stakeholders for Herpes Patient Advocacy

USE YOUR VOICE FOR CHANGE How long until a herpes cure? When asking this question – ask yourself, what can I do to help? Want to know when the nextContinueContinue reading “Key Stakeholders for Herpes Patient Advocacy”

New HSV Advocates: A Starters Guide to Activism

Getting started with Herpes Advocacy Step 1: Get Informed GET INFORMED: Make sure you know the Herpes 101 facts so you can speak to them in your advocacy. Read theContinueContinue reading “New HSV Advocates: A Starters Guide to Activism”

Pritelivir: Clinical Trial Recruiting for resistant Herpes Simplex Virus Infection in immune compromised Patients

AiCuris AG, a German biotech company, is currently recruiting for their clinical trial on Pritelivir. Pritelivir is a highly anticipated new treatment for resistant Herpes Simplex Virus infections that cannotContinueContinue reading “Pritelivir: Clinical Trial Recruiting for resistant Herpes Simplex Virus Infection in immune compromised Patients”